165 related articles for article (PubMed ID: 8080998)
1. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
2. Potent vitamin D3 analogs: their abilities to enhance transactivation and to bind to the vitamin D3 response element.
Imai Y; Pike JW; Koeffler HP
Leuk Res; 1995 Mar; 19(3):147-58. PubMed ID: 7700077
[TBL] [Abstract][Full Text] [Related]
3. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
4. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
5. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
[TBL] [Abstract][Full Text] [Related]
6. 1alpha,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1alpha,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells.
Siu-Caldera ML; Clark JW; Santos-Moore A; Peleg S; Liu YY; Uskoković MR; Sharma S; Reddy GS
J Steroid Biochem Mol Biol; 1996 Dec; 59(5-6):405-12. PubMed ID: 9010346
[TBL] [Abstract][Full Text] [Related]
7. Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.
Zhou JY; Norman AW; Akashi M; Chen DL; Uskokovic MR; Aurrecoechea JM; Dauben WG; Okamura WH; Koeffler HP
Blood; 1991 Jul; 78(1):75-82. PubMed ID: 1648977
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 induces differentiation of a retinoic acid-resistant acute promyelocytic leukemia cell line (UF-1) associated with expression of p21(WAF1/CIP1) and p27(KIP1).
Muto A; Kizaki M; Yamato K; Kawai Y; Kamata-Matsushita M; Ueno H; Ohguchi M; Nishihara T; Koeffler HP; Ikeda Y
Blood; 1999 Apr; 93(7):2225-33. PubMed ID: 10090931
[TBL] [Abstract][Full Text] [Related]
9. Metabolism of 1alpha,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation.
Campbell MJ; Drayson MT; Durham J; Wallington L; Siu-Caldera ML; Reddy GS; Brown G
Mol Cell Endocrinol; 1999 Mar; 149(1-2):169-83. PubMed ID: 10375029
[TBL] [Abstract][Full Text] [Related]
10. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptor-retinoid X receptor heterodimers on vitamin D3 responsive elements.
Verlinden L; Verstuyf A; Quack M; Van Camp M; Van Etten E; De Clercq P; Vandewalle M; Carlberg C; Bouillon R
J Bone Miner Res; 2001 Apr; 16(4):625-38. PubMed ID: 11315990
[TBL] [Abstract][Full Text] [Related]
11. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of 1,25-dihydroxyvitamin D3 stimulated osteocalcin gene transcription by tumor necrosis factor-alpha: structural determinants within the vitamin D response element.
Kuno H; Kurian SM; Hendy GN; White J; deLuca HF; Evans CO; Nanes MS
Endocrinology; 1994 Jun; 134(6):2524-31. PubMed ID: 8194478
[TBL] [Abstract][Full Text] [Related]
13. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
14. 1,25-Dihydroxyvitamin D3 receptor RNA: expression in hematopoietic cells.
Kizaki M; Norman AW; Bishop JE; Lin CW; Karmakar A; Koeffler HP
Blood; 1991 Mar; 77(6):1238-47. PubMed ID: 1705836
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional activity of a fluorinated vitamin D analog on VDR-RXR-mediated gene expression.
Sasaki H; Harada H; Handa Y; Morino H; Suzawa M; Shimpo E; Katsumata T; Masuhiro Y; Matsuda K; Ebihara K
Biochemistry; 1995 Jan; 34(1):370-7. PubMed ID: 7819220
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
Munker R; Norman A; Koeffler HP
J Clin Invest; 1986 Aug; 78(2):424-30. PubMed ID: 3461004
[TBL] [Abstract][Full Text] [Related]
17. Actions of vitamin D3, analogs on human prostate cancer cell lines: comparison with 1,25-dihydroxyvitamin D3.
Skowronski RJ; Peehl DM; Feldman D
Endocrinology; 1995 Jan; 136(1):20-6. PubMed ID: 7530193
[TBL] [Abstract][Full Text] [Related]
18. Singly dehydroxylated A-ring analogues of 19-nor-1alpha,25-dihydroxyvitamin D3 and 19-nor-22-oxa-1alpha,25-dihydroxyvitamin D3: novel vitamin D3 analogues with potent transcriptional activity but extremely low affinity for vitamin D receptor.
Okano T; Nakagawa K; Tsugawa N; Ozono K; Kubodera N; Osawa A; Terada M; Mikami K
Biol Pharm Bull; 1998 Dec; 21(12):1300-5. PubMed ID: 9881643
[TBL] [Abstract][Full Text] [Related]
19. Analysis of vitamin D analog-induced heterodimerization of vitamin D receptor with retinoid X receptor using the yeast two-hybrid system.
Zhao XY; Eccleshall TR; Krishnan AV; Gross C; Feldman D
Mol Endocrinol; 1997 Mar; 11(3):366-78. PubMed ID: 9058382
[TBL] [Abstract][Full Text] [Related]
20. Tissue specific metabolism of 1alpha,25-dihydroxy-20-epi-vitamin D3 into new metabolites with significant biological activity: studies in rat osteosarcoma cells (UMR 106 and ROS 17/2.8).
Siu-Caldera ML; Rao DS; Astecker N; Weiskopf A; Vouros P; Konno K; Fujishima T; Takayama H; Peleg S; Reddy GS
J Cell Biochem; 2001; 82(4):599-609. PubMed ID: 11500938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]